Risperdal Claims for Gynecomastia and Illegal Marketing

Risperdal Claims for Gynecomastia and Illegal Marketing

Risperdal lawsuits blame Johnson & Johnson for hiding serious side effects, including gynecomastia.

A 2019 Risperdal lawsuit ended in an $8 billion verdict against the company. Johnson & Johnson had previously agreed to two Risperdal settlements for $181 million and $2.2 billion to resolve charges that it had promoted the drug for off-label uses.


About TriMark

TriMark Legal Funding provides Risperdal pre settlement funding to injured plaintiffs nationwide.

This post originally appeared here: https://www.drugwatch.com/risperdal/lawsuits/

Click here to see the full original article.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408